Decoquinate/Levamisole Compounded Oral Paste

Description

Decoquinate/Levamisole Compounded Oral Paste is a prescription compounded medication prepared for horses. The combination may be prescribed by a veterinarian as part of an individualized treatment plan for equine protozoal myeloencephalitis (EPM).

Decoquinate provides antiprotozoal activity, while levamisole is an antiparasitic agent with immunomodulatory properties. The compounded oral paste provides both active ingredients in a palatable formulation designed for convenient administration to horses.

This compounded medication is prepared pursuant to a patient-specific veterinary prescription and is not an FDA-approved commercial drug product.

Uses & Benefits

• May be prescribed as part of veterinarian-directed management of EPM

• Combines decoquinate and levamisole in one compounded preparation

• Provides antiprotozoal activity from decoquinate

• Levamisole provides antiparasitic and immunomodulatory activity

• Oral paste provides a convenient administration option for horses

• Palatable formulation designed for equine administration

• Prepared according to an individual veterinary prescription

How It Works

Decoquinate is an antiprotozoal agent that interferes with mitochondrial electron transport in susceptible protozoa, disrupting energy production.

Levamisole is an antiparasitic agent that acts on susceptible parasites through nicotinic acetylcholine receptors. It also has immunomodulatory activity, which is one reason it may be incorporated into veterinarian-directed compounded protocols.

Indications

Veterinarian-Directed Management of Equine Protozoal Myeloencephalitis (EPM)

Ingredients

Active Ingredients:

Decoquinate / Levamisole

Inactive Ingredients:

Refer to manufacturer label for complete inactive ingredient information.

Directions

Follow the prescription label exactly and veterinarian directions.

Administer orally exactly as prescribed by your veterinarian. The compounded paste is dispensed in a calibrated oral dosing syringe to facilitate accurate administration.

Do not change the prescribed amount, frequency, or duration of treatment without veterinarian direction.

Cautions

• Prescription medication.

• For veterinary use in horses as prescribed.

• This is a compounded preparation and is not an FDA-approved commercial drug product.

• Use only under the direction of a licensed veterinarian.

• Do not administer to animals with known hypersensitivity to decoquinate, levamisole, or components of the formulation.

• Tell your veterinarian about all medications and supplements your horse receives before beginning treatment.

• Contact your veterinarian if neurologic signs worsen or the horse develops an unexpected reaction during treatment.

• Keep out of reach of children and animals.

Possible Side Effects

Decreased Appetite / Gastrointestinal Upset / Salivation / Excitability / Tremors / Other Unexpected Reactions

Precautions

EPM is a neurologic disease that requires veterinary diagnosis and management. Horses with suspected EPM should receive appropriate veterinary evaluation before treatment.

Because this is a compounded medication, the prescribed amount and treatment protocol are individualized for the horse. Do not substitute another decoquinate or levamisole product or change the treatment regimen without veterinarian authorization.

Use in breeding, pregnant, or lactating horses only when specifically directed by a veterinarian.

Storage

Store at room temperature according to the prescription label. Refrigeration is not required for this compounded oral paste. Keep the container securely closed and protect from excessive heat, moisture, and direct light.

Disposal

Dispose of unused or expired Decoquinate/Levamisole Compounded Oral Paste through a medication take-back program when available or according to applicable local medication disposal requirements. Keep discarded medication and packaging securely inaccessible to children and animals.